Skip to main content
OpenTrials

Clinical trial condition

Chronic Obstructive Pulmonary Disease (COPD)

Explore clinical trials studying Chronic Obstructive Pulmonary Disease (COPD). Study availability and eligibility vary by location and protocol.

428 public trials 59 recruiting studies
Refine in advanced search Browse all conditions

Chronic Obstructive Pulmonary Disease (COPD) trial results

Completed

Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01001494

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Almirall Investigational Sites#4 Benešov, Czechia
  • Almirall Investigational Sites#9 Jaroměř, Czechia
  • Almirall Investigational Sites#3 Liberec, Czechia
  • Almirall Investigational Sites#2 Lovosice, Czechia
View all 106 locations
View Trial Details
Completed

Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127)

NCT00313209

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Altana Pharma/Nycomed Investigational Site Linz, Austria
  • Altana Pharma/Nycomed Investigational Site Neusiedl/See, Austria
  • Altana Pharma/Nycomed Investigational Site Perg, Austria
  • Altana Pharma/Nycomed Investigational Site Salzburg, Austria
View all 134 locations
View Trial Details
Completed

To Determine the Relationship Between Baseline Reversibility and the Efficacy of Indacaterol

NCT01272362

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Ferolles-Attily, France
  • Novartis Investigative Site Suresnes, France
  • Novartis Investigative Site Vernon, France
  • Novartis Investigative Site Abbeville, France
View all 137 locations
View Trial Details
Completed

A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

NCT02153489

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Pulmonary Research Institute at the Lung Clinic Grosshansdorf Großhansdorf, Germany
  • Pneumologische Lehrklinik der Universitätsmedizin Göttingen Immenhausen, Germany
View Trial Details
Completed

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)

NCT00297115

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Altana Pharma/Nycomed Investigational Site Bayou La Batre, Alabama, United States
  • Altana Pharma/Nycomed Investigational Site Birmingham, Alabama, United States
  • Altana Pharma/Nycomed Investigational Site Birmingham, Alabama, United States
  • Altana Pharma/Nycomed Investigational Site Huntsville, Alabama, United States
View all 287 locations
View Trial Details
Completed

Clinical Trials for Elderly Patients With Multiple Disease

NCT01960907

Conditions
Apnea, Cardiovascular Diseases, Chronic Disease, +18 more
Locations
  • Institute of Clinical Medicine Tallinn, Estonia
  • Bolnisnica Sežana Zavod Sežana, Slovenia
  • Hospital clinic Barcelona, Spain
  • Uppsala University Hospital Uppsala, Sweden
View Trial Details

Related conditions